Open Access Repository

Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Aboy, M, Crespo, C, Liddell, K, Liddicoat, J ORCID: 0000-0001-7370-3936 and Jordan, M 2018 , 'Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?' , Nature Biotechnology, vol. 36, no. 12 , pp. 1146-1149 , doi: 10.1038/nbt.4308.

Full text not available from this repository.

Abstract

Five years later, what are the wider impacts of the US Supreme Court's Myriad decision on subject-matter eligibility and patent prosecution for nature-based products beyond isolated DNA?

Item Type: Article
Authors/Creators:Aboy, M and Crespo, C and Liddell, K and Liddicoat, J and Jordan, M
Keywords: patent law, DNA, Myriad, USA
Journal or Publication Title: Nature Biotechnology
Publisher: Nature Publishing Group
ISSN: 1087-0156
DOI / ID Number: 10.1038/nbt.4308
Copyright Information:

Copyright © 2018, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP